David I. Sandoval

Insider Reports History

Entity
Individual
Location
C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD
Signature
/s/ Katie Kazem, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David I. Sandoval:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. GENERAL COUNSEL Common Stock 45.9K $211K $4.60 Mar 15, 2024 Direct
MAXCYTE, INC. GENERAL COUNSEL Employee Stock Option (right to buy) 15.6K Mar 15, 2024 Direct

Insider Reports Filed by David I. Sandoval

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MXCT MAXCYTE, INC. Mar 15, 2024 2 $0 4 Mar 19, 2024 GENERAL COUNSEL
MXCT MAXCYTE, INC. Feb 22, 2024 0 $0 3 Mar 4, 2024 General Counsel